Association Between Thrombolytic Door-to-Needle Times and Ischemic Stroke Outcomes

This cohort study estimates associations between intravenous tissue plasminogen activator (tPA) door-to-needle times of less than 4.5 hours for acute ischemic stroke and 1-year mortality or readmission among Medicare beneficiaries aged 65 years or older.
Source: JAMA - Category: General Medicine Source Type: research